Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women
Open accessAbstract
Objective To investigate the association between bilateral oophorectomy and cognitive performance in healthy, older women. Design Retrospective analysis of clinical trial data. Setting Academic research institution. Patient(s) Healthy postmenopausal women without signs or symptoms of cardiovascular disease or diabetes (n = 926). Intervention(s) Randomized interventions (not the focus of this analysis) in analyzed trials included B-vitamins, soy isoflavones, oral estradiol, and matching placebos. Main outcome measure(s) Measures in five cognitive domains (executive functions, semantic memory, logical memory, visual memory, and verbal learning) and global cognitive function. Result(s) Using data from three clinical trials conducted under uniform conditions, bilateral oophorectomy and its timing were analyzed cross-sectionally and longitudinally in relation to cognitive function in linear regression models. Covariates included age, education, race/ethnicity, body mass index, trial, and randomized treatment (in longitudinal models). Duration of menopausal hormone use was considered as a possible mediator and effect modifier. Median age of oophorectomy was 45 years. When evaluating baseline cognition, we found that surgical menopause after 45 years of age was associated with lower performance in verbal learning compared with natural menopause. Evaluating the change in cognition over approximately 2.7 years, surgical menopause was associated with performance declines in visual memory for those who had an oophorectomy after 45 years of age and in semantic memory for those who had oophorectomy before 45 years of age compared with natural menopause. Oophorectomy after natural menopause was not associated with cognitive performance. Adjustment for duration of hormone use did not alter these associations. Conclusion(s) Cognitive associations with ovarian removal vary by timing of surgery relative to both menopause and age.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Undergoing surgical menopause is associated with increased risk of cognitive complaints and cognitive performance declines, particularly if surgery occurs before age 40 or natural menopause.
“However, undergoing surgical menopause is associated with increased risk of cognitive complaints, cognitive performance declines, and possibly increased dementia risk, particularly if surgery occurs before age 40 or natural menopause [2–7].”
From Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine (2024) · cites this paper as [5]
The Results (page not provided) associate surgical menopause before natural menopause with declines in specific cognitive domains, with findings differing for surgery before versus after age 45. The paper does not establish a particular threshold at age 40, and its cognitive-test outcomes do not support the claim about cognitive complaints. (LLM, conf=0.88)
Experimental — accuracy not yet measuredSurgical menopause is associated with more severe cognitive impairments relative to natural postmenopause; younger age at surgical menopause worsens these cognitive outcomes.
“Surgical menopause is associated with more severe cognitive impairments relative to natural postmenopause; younger age at surgical menopause worsens these cognitive outcomes [3,5,6].”
From Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine (2024) · cites this paper as [5]
The Results and Discussion report poorer performance or decline in specific cognitive domains after surgical menopause compared with natural menopause. They do not show that younger surgical menopause uniformly worsens cognitive outcomes: surgery before and after age 45 was associated with declines in different domains, and the Results state that age at menopause itself was not associated with cognitive function. (LLM, conf=0.87)
Experimental — accuracy not yet measuredUndergoing surgical menopause is possibly associated with increased dementia risk.
“However, undergoing surgical menopause is associated with increased risk of cognitive complaints, cognitive performance declines, and possibly increased dementia risk, particularly if surgery occurs before age 40 or natural menopause [2–7].”
From Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine (2024) · cites this paper as [5]
The Results report declines in some measures of cognitive performance after surgical menopause, but the study does not report dementia incidence or risk. A search for “dementia” found it in reference titles, not in a passage stating the claimed association. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049 · see citing works
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women
Bove, R., Secor, E., Chibnik, L. B., Barnes, L. L., Schneider, J. A., Bennett, D. A., & De Jager, P. L. (2014) · Neurology · doi:10.1212/wnl.0000000000000033 · Cited by 437 · see citing works
Hysterectomy, Oophorectomy, Estrogen, and the Risk of Dementia
Rocca, W. A., Grossardt, B. R., Shuster, L. T., & Stewart, E. A. (2012) · Neurodegenerative Diseases · doi:10.1159/000334764 · Cited by 122 · see citing works
Flagged first, then by citations
Research works printed but not linked: 31
- [1]Laughlin GA Barrett-Connor E Kritz-Silverstein D von Muhlen D Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study J Clin Endocrinol Metab 2000 85 645 51 10690870
- [2]Nappi RE Sinforiani E Mauri M Bono G Polatti F Nappi G Memory functioning at menopause: impact of age in ovariectomized women Gynecol Obstet Invest 1999 47 29 36 9852389
- [3]Farrag AK Khedr EM Abdel-Aleem H Rageh TA Effect of surgical menopause on cognitive functions Dement Geriatr Cogn Disord 2002 13 193 8 11893842
- [5]Costa A Nappi RE Sinforiani E Bono G Poma A Nappi G Cognitive function at menopause: neuroendocrine implications for the study of the aging brain Funct Neurol 1997 12 175 80 9218973
- [6]Szklo M Cerhan J Diez-Roux AV Chambless L Cooper L Folsom AR Estrogen replacement therapy and cognitive functioning in the Arthero-sclerosis Risk in Communities (ARIC) Study Am J Epidemiol 1996 144 1048 57 8942436
- [7]Kok HS Kuh D Cooper R vander Schouw YT Grobbee DE Wadsworth ME Cognitive function across the life course and the menopausal transition in a British birth cohort Menopause 2006 13 19 27 16607095
- [8]Fischer B Gleason C Asthana S Effects of hormone therapy on cognition and mood Fertil Steril 2014 101 898 904 24680649 PMC4330961
- [9]Hogervorst E Bandelow S Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials Maturitas 2010 66 56 71 20202765
- [10]Henderson VW Sherwin BB Surgical versus natural menopause: cognitive issues Menopause 2007 14 572 9 17476147
- [11]Rocca WA Grossardt BR Shuster LT Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity Brain Res 2011 1379 188 98 20965156 PMC3046246
- [12]Harman SM Naftolin F Brinton EA Judelson DR Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence Ann NY Acad Sci 2005 1052 43 56 16024750
- [13]Newman MF Kirchner JL Phillips-Bute B Gaver V Grocott H Jones RH Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery N Eng J Med 2001 344 395 402 11172175
- [14]Van Dijk D Keizer AM Diephuis JC Durand C Vos LJ Hijman R Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review J Thorac Cardiovasc Surg 2000 120 632 9 11003741
- [16]Lobo RA Surgical menopause and cardiovascular risks Menopause 2007 14 562 6 17476145
- [17]Tikhonoff V Casiglia E Guidotti F Giordano N Martini B Mazza A Body fat and the cognitive pattern: a population-based study Obesity (Silver Spring) 2015 23 1502 10 26110893
- [18]Hughes TF Borenstein AR Schofield E Wu Y Larson EB Association between late-life body mass index and dementia: the Kame Project Neurology 2009 72 1741 6 19451529 PMC2683740
- [20]Simpson E Rubin G Clyne C Robertson K O'Donnell L Jones M The role of local estrogen biosynthesis in males and females Trends Endocrinol Metab 2000 11 184 8 10856920
- [21]Hodis HN Mack WJ Dustin L Mahrer PR Azen SP Detrano R High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial Stroke 2009 40 730 6 19118243 PMC2701290
- [22]Henderson VW St John JA Hodis HN Kono N McCleary CA Franke AA Long-term soy isoflavone supplementation and cognition in women a randomized, controlled trial Neurology 2012 78 1841 8 22665144 PMC3369523
- [23]Henderson VW St John JA Hodis HN McCleary CA Stanczyk FZ Karim R Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause Proc Natl Acad Sci USA 2013 110 20290 5 24277815 PMC3864289
- [25]Phung TK Waltoft BL Laursen TM Settnes A Kessing LV Mortensen PB Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study Dement Geriatr Cogn Disord 2010 30 43 50 20689282
- [26]Gatto NM Henderson VW St John JA McCleary C Hodis HN Mack WJ Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2008 15 627 41 18608045 PMC2742696
- [27]Gatto NM Henderson VW St John JA McCleary C Detrano R Hodis HN Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular diseasel Int J Geriatr Psychiatry 2009 24 390 9 18836986 PMC2661006
- [29]Baron RM Kenny DA The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations J Pers Soc Psychol 1986 51 1173 82 3806354
- [30]Ryan J Scali J Carriere I Amieva H Rouaud O Berr C Impact of a premature menopause on cognitive function in later life BJOG 2014 121 1729 39 24802975
- [31]Verghese J Kuslansky G Katz MJ Sliwinski M Crystal HA Buschke H Cognitive performance in surgically menopausal women on estrogen Neurology 2000 55 872 4 10994013
- [32]Phillips SM Sherwin BB Effects of estrogen on memory function in surgically menopausal women Psychoneuroendocrinology 1992 17 485 95 1484915
- [33]American Congress of Obstetricians and Gynecologists (ACOG) ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy Obstet Gynecol 2008 111 231 41 18165419
- [34]Sherwin BB Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women Psychoendocrinology 1988 13 345 57 3067252
- [35]Shumaker SA Legault C Rapp SR Thal L Wallace RB Ockene JK Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 2003 289 2651 62 12771112
- [36]Shumaker SA Legault C Kuller L Rapp SR Thal L Lane DS Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study JAMA 2004 291 2947 58 15213206
Cited by
Sorted by citations
Metcalf, C. A., Page, C. E., Stocker, B. O. S., Johnson, R. L., Duffy, K. A., Sammel, M. D., Loughead, J., & Epperson, C. N. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.07.689 · Cited by 7 · see citing works
- Authors
- Kurita, K., Henderson, V. W., Gatz, M., St. John, J., Hodis, H. N., Karim, R., & Mack, W. J.
- Affiliations
- New York University (US)
- Stanford University (US)
- University of Southern California (US)
- Corresponding author
- Mack, Wendy J.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 106
- Issue
- 3
- Pages
- 749-756.e2
- ISSN
- 0015-0282 (ISSN-L)
- PMC
- PMC5743432
- OpenAlex
- W2347810373
- Cited by
- 42
- References
- 3
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 7 · 2017: 1 · 2016: 2
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Office of Research on Women's Health (U01AT001653)
- National Center for Complementary and Alternative Medicine
- National Institute on Aging (F31AG040937, R01AG17160, R01AG024154, P01AG026572, 5T32AG00037)
- Office of Dietary Supplements
- Health Resources and Services Administration (T32HP22238)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Keywords
- bilateral oophorectomy, cognitive function, surgical menopause, natural menopause, postmenopausal women, verbal learning, visual memory, semantic memory, executive function, hormone replacement therapy, ovarian removal
- MeSH terms
- Age Factors, Aged, Cognition, Cognition Disorders, Female, Humans, Memory, Middle Aged, Ovariectomy, Retrospective Studies, Risk Factors, Time Factors, Verbal Behavior, Linear Models, Randomized Controlled Trials as Topic, Treatment Outcome, Postmenopause, Executive Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review